Market Share of Canada Insulin Drugs And Delivery Devices Industry
The Canada Insulin Drugs and Delivery Devices Market is consolidated, with few significant and generic players. Mergers and acquisitions that happened between the players in the recent past have helped the companies strengthen their market presence. Eli Lilly and Boehringer Ingelheim have an alliance in developing and commercializing Basaglar (Insulin Glargine). Additionally, the players in the recent past helped the companies strengthen their market presence; for example, Novo Nordisk collaborated with Ypsomed to provide better insulin therapy solutions.
Canada Insulin Drugs And Delivery Devices Market Leaders
-
Roche
-
NovoNordisk
-
Sanofi
-
Medtronics
-
Eli Lilly
*Disclaimer: Major Players sorted in no particular order
